World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
89
Citations
27495
World Ranking
1119
National Ranking
99

Medicine

D-Index
89
Citations
27514
World Ranking
12746
National Ranking
1198

Costantino Pitzalis publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Costantino Pitzalis sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 587 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Costantino Pitzalis D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Costantino Pitzalis sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 89 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Costantino Pitzalis is affiliated with Queen Mary University of London in the United Kingdom. Their research focuses primarily on Medicine, with particular attention to Rheumatology, Immunology, Molecular Biology, Oncology, and Pathology and Forensic Medicine.

The main topics of their work include:

  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Lymphoma Diagnosis and Treatment
  • Autoimmune and Inflammatory Disorders Research
  • Monoclonal and Polyclonal Antibodies Research
  • Immune Cell Function and Interaction
  • Salivary Gland Disorders and Functions

Pitzalis has published extensively in various scientific outlets. Some of the frequent venues where their work appears include:

  • Annals of the Rheumatic Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Lara D. Veeken
  • Arthritis & Rheumatology
  • Nature Communications

Notable recent publications are:

  • Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis, 2020, Nature Medicine
  • Notch signalling drives synovial fibroblast identity and arthritis pathology, 2020, Nature
  • Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes, 2023, Nature
  • Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial, 2021, The Lancet
  • Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial, 2022, Nature Medicine

Frequent collaborators in Pitzalis's research include:

  • Myles Lewis
  • Felice Rivellese
  • Alessandra Nerviani
  • Stefano Bombardieri
  • Liliane Fossati-Jimack

Best Publications

  • Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry.

    Fan Zhang;Kevin Wei;Kamil Slowikowski;Chamith Y Fonseka

  • Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions.

    Robert Haas;Joanne Smith;Vidalba Rocher-Ros;Suchita Nadkarni

  • Ectopic lymphoid-like structures in infection, cancer and autoimmunity

    Costantino Pitzalis;Gareth Wyn Jones;Michele Bombardieri;Simon Arnett Jones

  • Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis.

    Stefano Alivernini;Lucy MacDonald;Aziza Elmesmari;Samuel Finlay

  • Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium

    Frances Humby;Michele Bombardieri;Antonio Manzo;Stephen Kelly

  • Mesenchymal multipotency of adult human periosteal cells demonstrated by single‐cell lineage analysis

    Cosimo De Bari;Francesco Dell'Accio;Johan Vanlauwe;Jeroen Eyckmans

  • Lactate Buildup at the Site of Chronic Inflammation Promotes Disease by Inducing CD4+ T Cell Metabolic Rewiring.

    Valentina Pucino;Valentina Pucino;Michelangelo Certo;Michelangelo Certo;Vinay Bulusu;Danilo Cucchi

  • A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide.

    S M Wellicome;M H Thornhill;C Pitzalis;D S Thomas

  • Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes

    Myles J. Lewis;Michael R. Barnes;Michael R. Barnes;Kevin Blighe;Katriona Goldmann

  • Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes

    Unknown

  • Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis.

    Sarah E. Headland;Hefin R. Jones;Lucy V. Norling;Andrew Kim

  • Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients

    Frances Humby;Myles Lewis;Nandhini Ramamoorthi;Jason A Hackney

  • The role of TNF‐α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera

    H Matsuno;K Yudoh;R Katayama;F Nakazawa

  • Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome

    F Barone;M Bombardieri;A Manzo;Mark Blades

  • Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.

    Simon J. Bowman;Colin C. Everett;John L. O'Dwyer;Paul Emery

  • Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.

    Antonio Manzo;Samantha Paoletti;Maresa Carulli;Mark C Blades

  • Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells

    Simon Rauber;Markus Luber;Stefanie Weber;Lisa Maul

  • Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

    Francesco Ciccia;Michele Bombardieri;Alfonso Principato;AnnaRita Giardina

  • Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

    Frances Humby;Frances Humby;Patrick Durez;Patrick Durez;Maya H Buch;Maya H Buch;Myles J Lewis;Myles J Lewis

  • The preferential accumulation of helper-inducer T lymphocytes in inflammatory lesions: evidence for regulation by selective endothelial and homotypic adhesion.

    Costantino Pitzalis;Gabrielle Kingsley;Dorian Haskard;Gabriel Panayi

  • In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses.

    Hayley G. Evans;Nicola J. Gullick;Stephen Kelly;Costantino Pitzalis

  • CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjögren's syndrome and MALT lymphoma: Association with reactive and malignant areas of lymphoid organization

    Francesca Barone;Michele Bombardieri;Manuela Maria Rosado;Peter Roger Morgan

Frequent Co-Authors

Michele Bombardieri
Michele Bombardieri Queen Mary University of London
Gabriel S. Panayi
Gabriel S. Panayi King's College London
Paul Emery
Paul Emery University of Leeds
Christopher D. Buckley
Christopher D. Buckley University of Oxford
Mauro Perretti
Mauro Perretti Queen Mary University of London
Carlomaurizio Montecucco
Carlomaurizio Montecucco University of Pavia
Iain B. McInnes
Iain B. McInnes University of Glasgow
Peter C. Taylor
Peter C. Taylor University of Oxford
Neil McHugh
Neil McHugh University of Bath
Roberto Caporali
Roberto Caporali University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, nursing offers a complementary career path with diverse opportunities in healthcare settings. Many students start by exploring online nursing programs for non nurses, designed to help individuals without prior nursing experience transition smoothly into this vital profession.

Accelerated programs are another popular choice for students eager to enter the nursing field quickly. These focused courses compress traditional timelines and are highlighted in guides about accelerated nursing programs, which balance speed with comprehensive education.

For those seeking entry-level roles, best easiest lpn programs to get into provide accessible pathways to become Licensed Practical Nurses (LPNs), offering practical experience in patient care within a shorter timeframe.

Advancing further, nurse practitioner degrees open doors to specialized practice and leadership in healthcare. Resources on easy nurse practitioner programs to get into guide prospective students toward options that balance program rigor with accessibility.

Overall, these online nursing degrees offer flexible solutions to complement an Immunology background, paving the way for impactful healthcare careers.

Best Scientists Citing Costantino Pitzalis

Trending Scientists

Recently Published Articles